Arete Wealth Advisors LLC Sells 1,698 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI)

Arete Wealth Advisors LLC decreased its holdings in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 7.8% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 20,158 shares of the exchange traded fund’s stock after selling 1,698 shares during the quarter. Arete Wealth Advisors LLC’s holdings in SPDR S&P Biotech ETF were worth $1,984,000 at the end of the most recent quarter.

Other large investors have also bought and sold shares of the company. Verition Fund Management LLC increased its holdings in SPDR S&P Biotech ETF by 18.2% in the third quarter. Verition Fund Management LLC now owns 98,292 shares of the exchange traded fund’s stock valued at $9,711,000 after purchasing an additional 15,116 shares during the last quarter. Captrust Financial Advisors grew its position in shares of SPDR S&P Biotech ETF by 135.5% during the 3rd quarter. Captrust Financial Advisors now owns 18,252 shares of the exchange traded fund’s stock worth $1,803,000 after buying an additional 10,501 shares during the period. Rockefeller Capital Management L.P. increased its stake in shares of SPDR S&P Biotech ETF by 41.7% in the 3rd quarter. Rockefeller Capital Management L.P. now owns 178,503 shares of the exchange traded fund’s stock valued at $17,636,000 after acquiring an additional 52,525 shares during the last quarter. Zurcher Kantonalbank Zurich Cantonalbank raised its position in shares of SPDR S&P Biotech ETF by 0.6% in the 3rd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 23,873 shares of the exchange traded fund’s stock valued at $2,373,000 after acquiring an additional 148 shares during the period. Finally, RPg Family Wealth Advisory LLC raised its position in shares of SPDR S&P Biotech ETF by 3.9% in the 3rd quarter. RPg Family Wealth Advisory LLC now owns 17,704 shares of the exchange traded fund’s stock valued at $1,749,000 after acquiring an additional 663 shares during the period.

SPDR S&P Biotech ETF Stock Performance

Shares of NYSEARCA XBI opened at $99.62 on Friday. The firm has a 50 day moving average price of $98.26 and a 200 day moving average price of $96.51. The stock has a market cap of $7.59 billion, a P/E ratio of 11.47 and a beta of 1.11. SPDR S&P Biotech ETF has a 52-week low of $74.20 and a 52-week high of $105.47.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.